When a worm is chopped in two, the missing part often re-grows.
Researchers at several biotech companies are challenging the assumption
that humans can’t perform a similar feat by developing drugs that
encourage self-regeneration.


Hydra Biosciences is
working a regeneration drug that stimulates heart muscle-cell regrowth,
and could lead to better recoveries for heart attack sufferers. The
protein-based drug induces mature cells to become a little bit like
stem cells.

By

Elizabeth Svoboda

More here.